A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

NCT00576732 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Autistic Disorder
Autism

Interventions

DRUG: Placebo
DRUG: Risperidone high dose
DRUG: Risperidone low dose

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.